ALBO Albireo Pharma Inc

Albireo Pharma Inc is a development-stage pharmaceutical company. It engages in the research and development of the drug reformulation technology. The company is engaged in the development an oral insulin to treat diabetes.

$35.82  -1.42 (-3.81%)
As of 03/02/2021 15:59:42 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
02/11/2013
19,113,603
185,787
$711,790,576
0.00%
SEC Edgar Online
10-Q
10-K
01345P106
US01345P1066
BYMP0T9

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-6.61
3.93
85.68
-59.39%
-1,295.53%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy